Cowealth Medical China Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	115.58	106.47	260.84	197.89	326.86	146.6
Short-Term Investments	-	42.98	-	-	-	-
Trading Asset Securities	-	-	-	-	10	-
Cash & Short-Term Investments	115.58	149.44	260.84	197.89	336.86	146.6
Cash Growth	-46.17%	-42.71%	31.81%	-41.25%	129.78%	-40.66%
Accounts Receivable	727.39	716.33	746.93	758.84	747.95	557.35
Other Receivables	1.6	1.58	2.15	7.65	4.77	6.89
Receivables	728.99	717.91	749.08	766.49	752.72	564.24
Inventory	165.94	172.64	201.88	196.87	204.82	178.86
Other Current Assets	105.36	84.29	79.18	93.54	116.95	80.14
Total Current Assets	1,116	1,124	1,291	1,255	1,411	969.85
Property, Plant & Equipment	150.45	152.92	118.95	118.53	81.98	88.27
Long-Term Investments	20.11	24.5	-	-	-	-
Other Intangible Assets	6.54	7	7.48	7.89	1.81	0.94
Long-Term Deferred Tax Assets	46.84	44.78	29.99	34.3	31.79	29.06
Long-Term Deferred Charges	17.9	18.73	21.9	17.78	13.82	23.43
Other Long-Term Assets	55.88	55.26	22.63	24	15.63	5.96
Total Assets	1,414	1,429	1,494	1,461	1,559	1,121
Accounts Payable	238.49	266.4	224.12	167.67	240.09	127.8
Accrued Expenses	6	11.39	14.85	43.4	40.11	37.82
Short-Term Debt	91.16	57.07	46.27	53.92	51.31	97.64
Current Portion of Long-Term Debt	1.97	1.48	2.22	8.84	8.69	10.15
Current Portion of Leases	-	0.72	1.34	2.51	3.44	3.41
Current Income Taxes Payable	2.39	1.15	5.11	7.08	14.56	13.99
Current Unearned Revenue	0.5	0.49	1.61	1.14	2.04	9.12
Other Current Liabilities	25.74	28.19	23.18	1.16	1.32	1.67
Total Current Liabilities	366.26	366.88	318.7	285.73	361.55	301.61
Long-Term Debt	1.48	1.9	-	2.18	10.84	11.99
Long-Term Leases	0.02	0.12	0.74	3.5	5.71	7.91
Other Long-Term Liabilities	-	-	-	1.08	2.38	3.28
Total Liabilities	367.76	368.9	319.44	292.49	380.49	324.78
Common Stock	398.05	398.05	398.05	398.05	398.05	298.54
Additional Paid-In Capital	596.74	596.74	596.62	596.65	596.65	336.1
Retained Earnings	77.09	85.37	170.76	167.08	179.6	168.53
Comprehensive Income & Other	-28.08	-22.28	6.03	5.02	3.44	-7.33
Total Common Equity	1,044	1,058	1,171	1,167	1,178	795.83
Minority Interest	2.03	1.74	3.16	2.11	0.83	-0.07
Shareholders' Equity	1,046	1,060	1,175	1,169	1,179	795.77
Total Liabilities & Equity	1,414	1,429	1,494	1,461	1,559	1,121
Total Debt	94.63	61.29	50.57	70.96	80	131.1
Net Cash (Debt)	20.95	88.16	210.28	126.93	256.86	15.5
Net Cash Growth	-88.05%	-58.08%	65.66%	-50.58%	1556.84%	-88.19%
Net Cash Per Share	0.05	0.21	0.53	0.32	0.68	0.05
Filing Date Shares Outstanding	414.25	398.05	398.05	398.05	398.05	398.05
Total Common Shares Outstanding	414.25	398.05	398.05	398.05	398.05	298.54
Working Capital	749.61	757.41	972.28	969.07	1,050	668.24
Book Value Per Share	2.52	2.66	2.94	2.93	2.96	2.67
Tangible Book Value	1,037	1,051	1,164	1,159	1,176	794.89
Tangible Book Value Per Share	2.50	2.64	2.92	2.91	2.95	2.66
Buildings	-	127.69	127.69	122.07	80.07	78.78
Machinery	-	47.89	57.95	67.42	83.41	86.82
Construction In Progress	-	39.51	-	-	-	-

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.